The conflicting data for low PRKAR1A/high SRC expression was associated with poor clinical outcome in human breast cancer derived from epithelium13; however, PRKAR1A was overexpressed in cholangiocarcinoma (CCA)29. This evidence concerns the gene PRKAR1A and cholangiocarcinoma.